Signaturefd, LLC Immuno Gen, Inc. Transaction History

Signaturefd, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$12.46 - $29.95 $2,180 - $5,241	175 Added 35.35%	670 $19,000
Q3 2023 Nov 03, 2023	BUY	$14.09 - $19.87 $4,720 - $6,656	335 Added 209.38%	495 $7,000
Q2 2023 Aug 01, 2023	BUY	$3.75 - $20.05 $371 - $1,984	99 Added 162.3%	160 $3,000
Q1 2023 Apr 28, 2023	BUY	$3.67 - $4.92 $47 - $63	13 Added 27.08%	61 $0
Q3 2022 Nov 08, 2022	BUY	$4.48 - $6.47 $215 - $310	48 New	48 $0
Q2 2022 Aug 10, 2022	SELL	$3.15 - $5.76 $796 - $1,457	-253 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$5.02 - $6.59 $90 - $118	-18 Reduced 6.64%	253 $1,000
Q4 2020 Feb 11, 2021	SELL	$3.7 - $7.66 $1,113 - $2,305	-301 Reduced 52.62%	271 $2,000
Q2 2020 Jul 30, 2020	SELL	$3.32 - $5.34 $116 - $186	-35 Reduced 5.77%	572 $3,000
Q4 2019 Feb 05, 2020	SELL	$2.25 - $5.8 $204 - $527	-91 Reduced 13.04%	607 $3,000
Q2 2019 Jul 31, 2019	BUY	$1.8 - $3.3 $766 - $1,405	426 Added 156.62%	698 $2,000
Q1 2019 May 09, 2019	SELL	$2.41 - $5.91 $255 - $626	-106 Reduced 28.04%	272 $1,000
Q4 2018 Feb 13, 2019	BUY	$3.94 - $9.7 $736 - $1,813	187 Added 97.91%	378 $2,000
Q3 2018 Nov 15, 2018	BUY	$8.6 - $11.26 $223 - $292	26 Added 15.76%	191 $2,000
Q2 2018 Aug 14, 2018	SELL	$9.52 - $12.15 $3,179 - $4,058	-334 Reduced 66.93%	165 $2,000
Q1 2018 May 08, 2018	BUY	$6.7 - $12.95 $3,343 - $6,462	499 New	499 $5,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.